Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn about a recent article by Pascal Hoffmann et al, published in Journal of Thrombosis and Haemostasis.
“A timely and highly relevant overview on gene therapy in hemophilia.
As we move from substitution therapy toward potential functional cure, the key challenge is no longer innovation itself—but how we implement it safely, equitably, and sustainably in real-world practice.
Important questions remain:
patient selection, long-term safety, durability of expression, and global accessibility.
This article is a valuable step toward structured, evidence-based navigation of this new era.”
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn:
“Overview of gene therapy for hemophilia: questions and answers to navigate the innovation
Gene therapy transforms hemophilia treatment through potentially one-time interventions targeting genetic deficiencies, achieving sustained factor expression and reduced bleeding with AAV-based approaches, though immunosuppressive management remains necessary for post-infusion complications.”
Title: Overview of gene therapy for hemophilia: questions and answers to navigate the innovation
Authors: Pascal Hoffmann, Niccolò Bitto, Vincenzo La Mura, Wolfgang Miesbach
Read the Full Article on Journal of Thrombosis and Haemostasis
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers